Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 4,235 KRW
Change Today +245.00 / 6.14%
Volume 360.7K
As of 2:29 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

hyundai pharmaceutical co lt (004310) Snapshot

Open
3,945
Previous Close
3,990
Day High
4,235
Day Low
3,860
52 Week High
07/3/15 - 6,460
52 Week Low
11/6/14 - 2,305
Market Cap
118.6B
Average Volume 10 Days
642.4K
EPS TTM
60.00
Shares Outstanding
28.0M
EX-Date
11/27/14
P/E TM
70.6x
Dividend
45.00
Dividend Yield
1.06%
Current Stock Chart for HYUNDAI PHARMACEUTICAL CO LT (004310)

Related News

No related news articles were found.

hyundai pharmaceutical co lt (004310) Related Businessweek News

No Related Businessweek News Found

hyundai pharmaceutical co lt (004310) Details

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical equipment. It offers a range of ETC and OTC products in various therapeutic areas, including antimocrobials, antiviral drugs, antineoplastic and immunology, cardiovascular, central nervous system, contraceptives, depilatory, dermatological agent, diagnostic reagent, digestive and endocrine system, ENT, hemostatics, harmone therapy, musculo-skeletal system, ophthalmic product, oral disease, respiratory, and urogenital system, as well as in alopecia treatment, anemia, arthritis, constipation, lipcare, nutrition, and wound healing. The company was founded in 1965 and is headquartered in Seoul, South Korea.

Founded in 1965

hyundai pharmaceutical co lt (004310) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hyundai pharmaceutical co lt (004310) Key Developments

Hyundai Pharmaceutical Co., Ltd., Annual General Meeting, Feb 12, 2015

Hyundai Pharmaceutical Co., Ltd., Annual General Meeting, Feb 12, 2015., at 10:00 Korea Standard Time. Location: Headquarters Conference Room, Dong, Nam-gu, Cheonan pungsemyeon 55 Zandari way modern medicine Ltd.. Agenda: To approve financial statements; to approve appointment of Audit Committee; and to approve remuneration ceiling.

Hyundai Pharmaceutical Co., Ltd., Annual General Meeting, Feb 13, 2014

Hyundai Pharmaceutical Co., Ltd., Annual General Meeting, Feb 13, 2014., at 10:00 Korea Standard Time. Location: dong, Nam-gu, Cheonan Hyundai 55 pungsemyeon street drugs. Agenda: To consider approval of financial statements; to consider incorporation of some changes; to consider election of directors; and to consider approval of directors' remuneration limit.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
004310:KS 4,235.00 KRW +245.00

004310 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 004310.
View Industry Companies
 

Industry Analysis

004310

Industry Average

Valuation 004310 Industry Range
Price/Earnings 63.3x
Price/Sales 0.8x
Price/Book 0.9x
Price/Cash Flow 58.1x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HYUNDAI PHARMACEUTICAL CO LT, please visit www.hyundaipharm.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.